San Francisco, 29 October 2018 , Global bioinformatics services market is
anticipated to reach USD 4.1 billion by 2024, according to a new report by
Grand View Research, Inc. Growing adoption of I.T. solutions for different
studies such as cell signaling, pathway metabolism, gene-receptor interactions,
and target differentiation are expected to support growth in this market over
the forecast period.
Owing to the
benefits associated with the use of informatic solutions for laboratory
protocol generation and data management as well as analysis, these solutions
are projected to witness substantial demand in the coming years.
Moreover,
collaborative activities undertaken by the information technology companies
with pharmaceutical companies and clinical research organizations in order to
develop and update key technologies linked to cloud computing, like online data
storage and visualization of computer resources are expected to enhance market
potential through to 2024.
Full Research Report On Bioinformatics Services Market Analysis:
www.grandviewresearch.com/industry-analysis/bioinformatics-services-market
www.grandviewresearch.com/industry-analysis/bioinformatics-services-market
Further key findings from the report suggest:
·
NGS is estimated to be the dominant segment
with respect to the type of service served in 2015 owing to the fact that
sequence-based approach of analysis can be cataloged with the structure-based
approach as complementary to genomic and proteomic approaches. Advancement in
the sequencing technologies such as NGS and scripting tools (Perl & Python)
for sequence manipulation coupled with the reduction in prices of the
sequencing platforms and market movement towards the USD 1,000 genome resulted
in a larger revenue share of this segment in the discovery informatics.
·
Market revenue from of chemoinformatics is
second only to NGS and its strong market position can be accounted for by
presence of several entities operating in this segment and their involvement in
the provision of lead identification, validation, assay development, lead
generation, optimization, and clinical trial based informatic solutions.
·
Depending on the application,
transcriptomics is anticipated to register the fastest growth of over 15% owing
to rise in the number of projects carried out in translational research and
application of RNA transcripts for studying etiology of chronic as well as acute
diseases.
·
Academic sector, in terms of end-use for
these services, is expected to witness the fastest growth through to 2024 as a
result of rise in the adoption rate of these technologies in genomic, proteomic
and metabolomics research programs carried out by universities research
institutes. If not all, most of these programs are either backed through
government funding or private corporation backing and forms a considerable part
of the high R&D investment that the bioinformatics market attracts in
the current scenario.
·
North America dominated the industry in
2015, accounting for a little 35% of total revenue. Presence of key
participants operating in the region which are involved in development of novel
algorithms and software in order to improve drug attrition rates which
consequently increases adoption rate of computational algorithms is attributive
for the largest share of North America in sector revenue. Demand for informatic
services in Europe is also increasing owing to the presence of universities in
Germany and UK that are involved in development of I.T. solutions for
pharmaceutical research.
·
Asia Pacific is estimated to witness the
fastest growth over the forecast period owing to the fact that government and
regulatory authorities have implemented a framework to encourage R&D
collaborations and framework extension. Active expansion strategies undertaken
by a number of the major market entities operating in the American market in
order to strengthen their position in Asia Pacific region is a factor
anticipated to consequently drive growth.
·
Key players operating in this industry
include Agilent technologies, Siegen Inc., GVK Biosciences, Accelerys Inc,
Illumina Inc., DNAnexus, Life Technologies Corporation, Geneva Bioinformatic,
Celera Corporation, IBM Life sciences, and Affymetrix.
·
These entities are adopting strategies such
as collaborations with pharmaceutical and biotechnology companies in order to
enhance industrial presence by providing different data management and
analytical services for the purpose of drug design and therapeutic monitoring.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented
bioinformatics services market on the basis of service type, sector,
application, and region:
Global
Bioinformatics Services Outlook, by Type (Revenue, USD Million, 2013 - 2024)
·
NGS
o
Targeted Sequencing Analysis
o
Transcriptome Analysis
o
Whole Genome
o
Chip Seq Analysis
o
De novo Assembly
o
Methyl Seq Analysis
·
Cheminformatics
o
Sequence Analysis Platforms
o
Molecular Modeling
o
Docking
o
Clinical trial data management
o
Others
·
Microarray data analysis
·
Biological data curation
·
Scientific software testing
·
Other services
Global
Bioinformatics Services Outlook, by Application (Revenue, USD Million, 2013 -
2024)
·
Genomics
·
Transcriptomics
·
Proteomics
·
Metabolomics
·
Drug Discovery
·
Others
Global
Bioinformatics Services Outlook, by Sector (Revenue, USD Million, 2013 - 2024)
·
Medical
·
Animal
·
Agricultural
·
Academics
Bioinformatics
Services Regional Outlook (Revenue, USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
·
MEA
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-bioinformatics-services-market
www.grandviewresearch.com/press-release/global-bioinformatics-services-market
About Grand View Research
Grand View Research, Inc.
is a U.S. based market research and consulting company, registered in the State
of California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting services.
To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/
